Envoy Medical, Inc.
Envoy Medical, Inc. (COCH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
coch · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$6.00
+810.5% upside
Low
$6.00
Median: $6 · Last Close: $0.66
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.66 | ↓ 0.57% |
1-day model range: $0.65–$0.66. Peak: $0.66 (-0.57%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · COCH · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-05-27 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-12-06 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-04-03 | Lake Street | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Envoy Medical, Inc. (COCH) stock. Of the recent 5 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover COCH.
Analyst Recommendation Trends
COCH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 98.6% YoY
Revenue Next Year
$0M
↑ 0.0% YoY
EPS This Year
$-1.19
EPS Next Year
$-0.30
↓ 74.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast COCH EPS of $-1.19 for the current fiscal year, based on estimates from 1 analysts. The COCH revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The COCH stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus COCH price target is $6.00 (+810.5% upside), with an analyst consensus of Buy.
The COCH short-term stock prediction for tomorrow is $0.66 (-0.57%).
Envoy Medical, Inc. trades on NASDAQ under the ticker COCH. The COCH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
COCH forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month COCH price target is $6.00, with a high forecast of $6.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +810.5% potential upside from the current price of $0.66.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.